Evaluation of combination study of Pterocarpus marsupium and tecoma stans for antidiabetic action

The present study investigates the anti-diabetic potential of Pterocarpus marsupium (heartwood extract) and Tecoma stans (leaf extract) in streptozotocin (STZ)-induced diabetic Wistar rats. Diabetes was induced via intraperitoneal injection of STZ (50 mg/kg). Rats were treated with individual extracts (200 mg/kg) and their combination for 21 days. Blood glucose, body weight, lipid profile, serum insulin, and histopathology of pancreatic tissue were evaluated. Both extracts significantly reduced fasting blood glucose and improved metabolic parameters. The combination group showed synergistic activity comparable to metformin. Findings support the potential of these plant extracts as complementary anti-diabetic agents.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-07-04
DOI
https://doi.org/10.5281/zenodo.15806208
Primary Topic
Natural Antidiabetic Agents Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of combination study of Pterocarpus marsupium and tecoma stans for antidiabetic action

Zenodo (CERN European Organization for Nuclear Research)
Natural Antidiabetic Agents Studies
article

Evaluation of combination study of Pterocarpus marsupium and tecoma stans for antidiabetic action

article en

Abstract

The present study investigates the anti-diabetic potential of Pterocarpus marsupium (heartwood extract) and Tecoma stans (leaf extract) in streptozotocin (STZ)-induced diabetic Wistar rats. Diabetes was induced via intraperitoneal injection of STZ (50 mg/kg). Rats were treated with individual extracts (200 mg/kg) and their combination for 21 days. Blood glucose, body weight, lipid profile, serum insulin, and histopathology of pancreatic tissue were evaluated. Both extracts significantly reduced fasting blood glucose and improved metabolic parameters. The combination group showed synergistic activity comparable to metformin. Findings support the potential of these plant extracts as complementary anti-diabetic agents.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 45%
Natural Antidiabetic Agents Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.